标题
Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies?
作者
关键词
-
出版物
Biomed Research International
Volume 2015, Issue -, Pages 1-9
出版商
Hindawi Limited
发表日期
2015-06-17
DOI
10.1155/2015/865101
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
- (2014) Lee M. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
- (2013) D. McDermott et al. ANNALS OF ONCOLOGY
- Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
- (2013) Jedd D. Wolchok et al. Annals of the New York Academy of Sciences
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of end points for cancer immunotherapy trials
- (2012) A. Hoos ANNALS OF ONCOLOGY
- Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
- (2012) O. J. Finn ANNALS OF ONCOLOGY
- Immunotherapy of cancer in 2012
- (2012) John M. Kirkwood et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cure Models as a Useful Statistical Tool for Analyzing Survival
- (2012) M. Othus et al. CLINICAL CANCER RESEARCH
- How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies
- (2012) Darius N. Lakdawalla et al. HEALTH AFFAIRS
- Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
- (2012) Jesús F. San Miguel et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Maintenance in Patients with Advanced Non–Small-Cell Lung Cancer, Clinical Patterns, and Outcomes in the Eastern Cooperative Oncology Group 4599 Study: Results of An Exploratory Analysis
- (2012) Ariel Lopez-Chavez et al. Journal of Thoracic Oncology
- The Cure Fraction of Glioblastoma Multiforme
- (2012) Nicolas R. Smoll et al. NEUROEPIDEMIOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
- (2012) S. A. Rosenberg Science Translational Medicine
- Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology
- (2012) Beth Sherrill et al. OncoTargets and Therapy
- Meaningful change in oncology quality-of-life instruments: a systematic literature review
- (2012) Gillian Bedard et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines
- (2011) Marijo Bilusic et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New Challenges in Endpoints for Drug Development in Advanced Melanoma
- (2011) A. Ribas et al. CLINICAL CANCER RESEARCH
- Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Clinical Evidence
- (2011) T. E. Hutson ONCOLOGIST
- Population-based survival-cure analysis of ER-negative breast cancer
- (2010) Lan Huang et al. BREAST CANCER RESEARCH AND TREATMENT
- Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007
- (2010) R. Sridhara et al. JNCI-Journal of the National Cancer Institute
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted therapies for renal cell carcinoma: understanding their impact on survival
- (2010) Sumanta Kumar Pal et al. Targeted Oncology
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study
- (2009) Dennis Yi-Shin Kuo et al. GYNECOLOGIC ONCOLOGY
- Methodological aspects of lung cancer clinical trials in the era of targeted agents
- (2009) Massimo Di Maio et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search